VASCULAR BASEMENT-MEMBRANE COMPONENTS AND THE LESIONS OF ALZHEIMERS-DISEASE - LIGHT AND ELECTRON-MICROSCOPIC ANALYSES

被引:45
作者
PERLMUTTER, LS
MYERS, MA
BARRON, E
机构
[1] Department of Neurology, University of Southern California School of Medicine, Los Angeles, California
关键词
HEPARAN SULFATE PROTEOGLYCAN; LAMININ; COLLAGEN; AMYLOID P COMPONENT; BETA-AMYLOID;
D O I
10.1002/jemt.1070280305
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Alzheimer's disease (AD) is one of several systemic and cerebral diseases that involve the abnormal deposition of fibrillar proteins called amyloids. All amyloids share conformational and staining characteristics, as well as an association with resident tissue macrophages and two extracellular matrix components [heparan sulfate proteoglycan (HSPG) and amyloid P component]. Vascular, glomerular, and Schwann cell basement membrane pathologies have been documented in many forms of amyloidosis, and often amyloid fibrils fuse to and project from the basement membrane in these diseases. The present report demonstrates the vascular basement membrane (VBM) alterations in AD autopsy samples, and details the methodologies used. Electron microscopy reveals the fusion of amyloid fibrils with the VBM and the alteration of the VBM in the absence of amyloid accumulation. Double-labelling and pre-embed immuno-electron microscopy techniques demonstrate the colocalization of amyloid P component and VBM components with amyloid, and also reveal that amyloid P component is not localized to the cerebral VBM. Finally, a novel correlative light/electron microscopy technique demonstrates the association between amyloid P component and cerebral resident tissue macrophages, the microglia. Taken together, these data suggest that the physicochemical processes of amyloid formation, rather than amyloid deposition, may be responsible for VBM pathology. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 103 条
[11]  
CATHCART ES, 1971, IMMUNOLOGY, V20, P945
[12]   STIMULATED PLATELETS RELEASE AMYLOID BETA-PROTEIN PRECURSOR [J].
COLE, GM ;
GALASKO, D ;
SHAPIRO, IP ;
SAITOH, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (01) :288-295
[13]   ABNORMAL PRODUCTION OF INTERLEUKIN-1 BY MICROGLIA FROM TRISOMY-16 MICE [J].
COLTON, CA ;
YAO, J ;
TAFFS, RE ;
KERI, JE ;
OSTERGRANITE, ML .
NEUROSCIENCE LETTERS, 1991, 132 (02) :270-274
[14]  
CORIA F, 1988, LAB INVEST, V58, P454
[15]   MICROGLIA ARE ASSOCIATED WITH THE EXTRACELLULAR NEUROFIBRILLARY TANGLES OF ALZHEIMER-DISEASE [J].
CRAS, P ;
KAWAI, M ;
SIEDLAK, S ;
PERRY, G .
BRAIN RESEARCH, 1991, 558 (02) :312-314
[16]   INTERLEUKIN-1 STIMULATES THE BETA-AMYLOID PRECURSOR PROTEIN PROMOTER [J].
DONNELLY, RJ ;
FRIEDHOFF, AJ ;
BEER, B ;
BLUME, AJ ;
VITEK, MP .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1990, 10 (04) :485-495
[17]  
DYCK RF, 1980, LANCET, V2, P607
[18]  
DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162
[19]  
DYCK RF, 1980, AMYLOID AMYLOIDOSIS, P50
[20]   EFFECTS OF SULFATE-IONS ON ALZHEIMER-BETA/A4 PEPTIDE ASSEMBLIES - IMPLICATIONS FOR AMYLOID FIBRIL PROTEOGLYCAN INTERACTIONS [J].
FRASER, PE ;
NGUYEN, JT ;
CHIN, DT ;
KIRSCHNER, DA .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (04) :1531-1540